Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-28, Stock:ABBV, The news for the past five days is as follows:
2018-02-21: NEWS1: How An AbbVie Deal Sent This Biotech Stock To A 2-Year High.NEWS2: ANTH Awaits RESULT In Mar., HAIR Grows, NITE Shines, TRXC On Must-watch List.NEWS3: ANTH Awaits RESULT In Mar., HAIR Grows, NITE Shines, TRXC On Must-watch List.NEWS4: Here’s What The AbbVie and Voyager Therapeutics Deal Really Means.NEWS5: Can Johnson & Johnson Replace Remicade for $100 Million Upfront?.NEWS6: Can Johnson & Johnson Replace Remicade for $100 Million Upfront?.NEWS7: AbbVie, Neurocrine shares rise after positive results for uterine fibroids drug.NEWS8: AbbVie Announces Positive Topline Results from Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids.NEWS9: Canadians living with Moderate to Severe Hidradenitis Suppurativa are beginning to have public access to HUMIRA® (Adalimumab) to manage their disease.NEWS10: AbbVie Reports Positive Topline Results From Phase 3 Elagolix Study.NEWS11: AbbVie Reports Positive Topline Results From Phase 3 Elagolix Study.NEWS12: Trial Tests FTC’s Power to Referee Drug Makers’ Fight Against Generics.
2018-02-22: NEWS1: Flowhub is Automating Cannabis From Seed to Sale.NEWS2: Dividend Companies Showering Shareholders With More Cash.NEWS3: February Pharma And Biotech Dividend Stocks To Look Out For.NEWS4: AbbVie to Present at the Cowen and Company 38th Annual Health Care Conference.NEWS5: In The Spotlight: Inflarx.NEWS6: In The Spotlight: Inflarx.NEWS7: Why TG Therapeutics Stock Jumped 10% Today.NEWS8: Why TG Therapeutics Stock Jumped 10% Today.
2018-02-23: NEWS1: The VIX manipulation scandal will be bigger than the LIBOR scandal.NEWS2: New Strong Buy Stocks for February 23rd.NEWS3: New Strong Buy Stocks for February 23rd.NEWS4: Pharma Stock Roundup: AZN's Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm.NEWS5: Pharma Stock Roundup: AZN's Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm.NEWS6: Pharma Stock Roundup: AZN&apos;s Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm.NEWS7: Here Are Today’s Biotech Movers: Abbvie, Neurocrine and GW Pharmaceuticals.NEWS8: Performance of Johnson & Johnson’s Remicade and Stelara in 2017.NEWS9: Abbvie's Uterine Fibrosis Candidate Meets Goal in Study.NEWS10: Abbvie's Uterine Fibrosis Candidate Meets Goal in Study.NEWS11: Abbvie&apos;s Uterine Fibrosis Candidate Meets Goal in Study.
2018-02-26: NEWS1: Johnson & Johnson’s Oncology Segment’s Performance in 2017.NEWS2: Gilead Sciences: The Oncology Company?.NEWS3: Gilead Sciences: The Oncology Company?.NEWS4: AbbVie (ABBV) Up 9.7% Since Earnings Report: Can It Continue?.NEWS5: AbbVie (ABBV) Up 9.7% Since Earnings Report: Can It Continue?.NEWS6: AbbVie to Present at the Barclays Global Healthcare Conference.NEWS7: AbbVie (ABBV) Up 9.7% Since Earnings Report: Can It Continue?.
2018-02-27: NEWS1: 3 Top Pharma Stocks With Dividend Yields Over 3%.NEWS2: Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP.NEWS3: Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP.NEWS4: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS5: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS6: ABBV Crosses Above Average Analyst Target.NEWS7: ABBV Crosses Above Average Analyst Target.NEWS8: Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP.NEWS9: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.

Answer: Decrease